Skip to content
MedsAcross

Medicine

Azithromycin 100 mg/5 mL powder for oral suspension

Azithromycin · Oral
Available on requestPrescription onlyUS FDAGeneric name

Azithromycin 100 mg/5 mL powder for oral suspension is a generic prescription medicine for oral use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Protect from freezing. Store dry powder at 20° to 25°C (68° to 77°F)…

Key facts

Active ingredient (INN)
Azithromycin
Brand
Sold under the generic name
Strength
100 mg/5 mL
Dosage form
Powder for oral suspension
Route
Oral
Packs
1 bottle, 15 mL and 10 more
Manufacturers
Zydus LifesciencesIndiaAurobindo PharmaIndiaNuCare Pharmaceuticals,IncA-S Medication SolutionsAiPing PharmaceuticalEpic PharmaPreferred PharmaceuticalsSlate Run PharmaceuticalsState Health Services, Texas Department ofTeva Pharmaceuticals
Origin register
US FDA, United States
Storage
Protect from freezing. Store dry powder at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F). Store constituted suspension between 5° to 30°C (41° to 86°F) and discard when full dosing is completed.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J01FA10 Azithromycin
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 December 2010
Identifiers
RxCUI 141963, 308459DailyMed set ID d6fb42ed-7dac-4a7b-9964-d367dd47dd5c, 0b63649d-558c-4250-90ee-af6e1e5c6d2c, 3c902990-b870-4725-b9fe-76b8be633e1c +10NDC 11788-128, 70771-1422, 59651-007 +10Application ANDA217036, ANDA211147, ANDA209201 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 bottle in 1 carton / 15 mL in 1 bottle70710-1457-1Zydus LifesciencesIndia6 August 2018
1 bottle in 1 carton / 15 mL in 1 bottle70771-1422-1Zydus LifesciencesIndia6 August 2018
1 bottle in 1 carton / 15 mL in 1 bottle59651-007-15Aurobindo PharmaIndia9 October 2018
1 bottle in 1 carton / 15 mL in 1 bottle11788-128-13AiPing Pharmaceutical16 January 2026
15 mL in 1 bottle, plastic42806-147-31Epic Pharma10 April 2018
1 bottle in 1 carton / 15 mL in 1 bottle70436-220-34Slate Run Pharmaceuticals1 January 2024
15 mL in 1 bottle55695-002-00State Health Services, Texas Department of28 December 2010
15 mL in 1 bottle0093-2027-23Teva Pharmaceuticals28 December 2010
1 bottle in 1 carton / 15 mL in 1 bottle72673-084-30Zhejiang Poly Pharm11 April 2025
15 mL in 1 bottle68071-1527-5NuCare Pharmaceuticals,Inc18 July 2017
15 mL in 1 bottle68071-5035-5NuCare Pharmaceuticals,Inc21 August 2019
15 mL in 1 bottle50090-1868-0A-S Medication Solutions10 June 2015
15 mL in 1 bottle68788-8675-1Preferred Pharmaceuticals23 May 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 1 November 1991Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Azithromycin

Clinical summary

Azithromycin is a macrolide antimicrobial indicated for treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below, among other approved uses. MedsAcross supplies Azithromycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Azithromycin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Azithromycin 100 mg/5 mL powder for oral suspension for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.